z-logo
open-access-imgOpen Access
Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia
Author(s) -
Christoph Röllig,
Michael Krämer,
Christoph Schliemann,
Jan-Henrik Mikesch,
Björn Steffen,
Alwin Krämer,
Tim Sauer,
Mathias Hänel,
Regina Herbst,
Kerstin SchäferEckart,
Richard Noppeney,
Edgar Jost,
Tim H. Brümmendorf,
Stefan W. Krause,
Volker Kunzmann,
Hermann Einsele,
Sebastian Scholl,
Andreas Hochhaus,
Lars Fransecky,
Martin Kaufmann,
Andreas Neubauer,
Dirk Niemann,
Markus Schaich,
Norbert Frickhofen,
Alexander Kiani,
Frank Heits,
Ulrich Krümpelmann,
Ulrich Kaiser,
Johannes Kullmer,
Maxi Wass,
Stefan Klein,
Malte von Bonin,
Jan Moritz Middeke,
Christian Thiede,
Friedrich Stoelzel,
Johannes Schetelig,
Gerhard Ehninger,
Claudia D. Baldus,
Carsten MüllerTidow,
Uwe Platzbecker,
Hubert Serve,
Martin Bornhäuser
Publication year - 2019
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood-2019-123717
Subject(s) - cytarabine , medicine , myeloid leukemia , acute promyelocytic leukemia , leukemia , acute leukemia , oncology , retinoic acid , biochemistry , chemistry , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom